MINI REVIEW
Published on 15 Nov 2022
Global perspectives on CYP2D6 associations with primaquine metabolism and Plasmodium vivax radical cure
doi 10.3389/fphar.2022.752314
- 1,618 views
- 2 citations
- Frontiers in Pharmacology
- Pharmacogenetics and Pharmacogenomics
- Research Topics
- Pharmacogenetics of Antimalarials – Primaquine for the Treatment of Plasmodium vivax and Plasmodium falciparum Malaria
Pharmacogenetics of Antimalarials – Primaquine for the Treatment of Plasmodium vivax and Plasmodium falciparum Malaria
6,506
Total downloads
27k
Total views and downloads
Submit your idea
Select the journal/section where you want your idea to be submitted:
Articles
PERSPECTIVE
Published on 26 Nov 2021
Genetic Variation of G6PD and CYP2D6: Clinical Implications on the Use of Primaquine for Elimination of Plasmodium vivax
doi 10.3389/fphar.2021.784909
- 2,675 views
- 7 citations
BRIEF RESEARCH REPORT
Published on 23 Jul 2021
CYP2D6 Allele Frequency in Five Malaria Vivax Endemic Areas From Brazilian Amazon Region
doi 10.3389/fphar.2021.542342
- 2,017 views
- 3 citations
ORIGINAL RESEARCH
Published on 20 Apr 2021
CYP2D6 Genetic Variation and Its Implication for Vivax Malaria Treatment in Madagascar
doi 10.3389/fphar.2021.654054
- 2,518 views
- 7 citations
ORIGINAL RESEARCH
Published on 09 Apr 2021
G6PD Polymorphisms and Hemolysis After Antimalarial Treatment With Low Single-Dose Primaquine: A Pooled Analysis of Six African Clinical Trials
doi 10.3389/fgene.2021.645688
- 3,185 views
- 2 citations
REVIEW
Published on 15 Mar 2021
G6PD Variants and Haemolytic Sensitivity to Primaquine and Other Drugs
doi 10.3389/fphar.2021.638885
- 12,430 views
- 32 citations
Published in
Frontiers in Pharmacology
- Pharmacogenetics and Pharmacogenomics
- Drug Metabolism and Transport
Participating Journals
Frontiers in Genetics
- 2.8 impact factor
- 5.5 citescore
Impact
- 27kTopic views
- 19kArticle views
- 6,506Article downloads